Economy 13 Panel Drug Test ETG with Fentanyl, Kratom & ADLTX – 90 mL

Economy 13 Panel Drug Test ETG with Fentanyl, Kratom & ADLTX

The 13 panel drug test ETG cup combines urine specimen collection, preliminary screening for 13 drugs, drug classes and metabolites, and three specimen-validity indicators in one compact 90 mL device.

This configuration is differentiated by dedicated ETG/300, FEN/20 and KRA/500 screening panels together with an OPI/2000 opiate assay. It also includes pH, specific gravity and creatinine specimen-validity checks that are evaluated separately from the 13 drug-screening panels.

The cup screens for amphetamines, buprenorphine, benzodiazepines, cocaine, EtG, fentanyl, MDMA, methamphetamine, methadone, opiates, oxycodone, THC and kratom-related targets.

Because products with the same panel count can use different analytes and cutoff concentrations, buyers should compare the complete configuration rather than selecting a cup based only on the “13 panel” designation.

This Economy 90 mL configuration is labeled Forensic Use Only. Buyers looking for another analyte combination can compare all available 13 panel drug test cups.

13 Panel Drug Test List and Cutoff Levels

The complete screening configuration is shown below. Each listed cutoff represents the screening decision threshold for the applicable qualitative assay.

Additional specimen-validity indicators: pH, specific gravity (SG) and creatinine (CR).

The pH, SG and CR indicators are not drug-screening panels and should not be included in the 13-panel count.

EtG, Fentanyl & Kratom Screening

The specialty-panel combination is the primary feature that distinguishes this 13 panel drug test ETG from other 13-panel configurations.

ETG/300 provides preliminary screening for ethyl glucuronide, an alcohol metabolite. EtG screening does not directly measure current blood-alcohol concentration or establish current impairment.

FEN/20 provides dedicated fentanyl screening separately from the OPI/2000 opiate assay. The presence of an opiate panel should not be treated as a substitute for a dedicated fentanyl assay.

KRA/500 provides kratom-related screening. KRA should not automatically be described as a dedicated 7-hydroxymitragynine assay unless the applicable manufacturer documentation specifically identifies 7-OH as the target analyte.

For additional information about kratom-related screening, review our 7-OH kratom testing guide or compare the standalone kratom urine test cartridge.

Why the OPI/2000 Cutoff Matters

This configuration uses an OPI/2000 screening cutoff. Other 13-panel products on DrugTestingCup.com may use OPI/300 or another opiate configuration.

That difference is important when comparing products because two cups can both be labeled “13 panel” while using different screening cutoffs for the same drug class.

The OPI/2000 panel also remains separate from FEN/20, OXY/100, BUP/10 and MTD/300. These assays should be reviewed individually rather than treated as one combined opioid result.

Economy 90 mL Cup Features

The Economy 90 mL format combines urine collection, multi-panel screening and three specimen-validity checks in one compact device.

• 90 mL cup capacity – compact integrated format
• 13 drug-screening assays – each with its own stated cutoff
• 3 specimen-validity indicators – pH, SG and creatinine
• Built-in temperature strip – provides an additional specimen reference after collection
• Dedicated specialty panels – EtG, fentanyl and kratom-related screening
• Forensic Use Only – use according to current product labeling

The 90 mL designation describes cup capacity. It does not mean exactly 90 mL of urine must be collected. Follow the specimen-volume requirement supplied with the product.

Benefits and Forensic Use Cases

This configuration combines conventional multi-panel urine screening with three specialty targets and specimen-validity checks. It can reduce the need to use separate rapid screening devices when the applicable forensic testing protocol requires EtG, fentanyl, kratom-related screening and specimen-validity assessment.

Organizations researching testing workflows for court supervision, probation, parole or correctional environments can review our probation drug testing and correctional screening guide.

The product remains subject to its individual Forensic Use Only labeling. A forensic-use designation should not be interpreted as automatically making the device equivalent to a CLIA-waived clinical test, OTC home test or Employment & Insurance product.

Specimen Validity Checks – pH, Specific Gravity & Creatinine

This 13 panel drug test with adulterants includes three additional specimen-validity indicators: pH, specific gravity and creatinine.

• pH: provides information about the acidity or alkalinity of the urine specimen.
• Specific Gravity (SG): provides information about specimen concentration.
• Creatinine (CR): provides another indicator related to urine concentration and possible dilution.

These indicators should be interpreted using the reference chart and timing requirements supplied with the exact device. The control/test-line rules used for drug assays do not apply to ADLTX pads.

An unusual specimen-validity result does not by itself prove intentional adulteration. Follow the applicable collection and review procedure when pH, SG or creatinine findings require additional evaluation.

For more information, see our guide to adulterants and specimen-validity testing.

How to Use and Read Results

Always follow the package insert supplied with the exact product lot because specimen requirements, device activation and interpretation times are determined by the manufacturer.

1. Confirm the correct product configuration, expiration date and sealed package condition before collection.
2. Collect urine directly into the cup to the required specimen level and secure the lid.
3. Complete any device-specific activation steps described in the product instructions.
4. Check the temperature strip and specimen-validity indicators according to their specified timing requirements.
5. Begin timing as directed and read each of the 13 drug-screening panels within the manufacturer’s interpretation window.
6. Document the results and follow the applicable procedure for invalid or preliminary non-negative screens.

• Negative: the required control line and test line appear for the applicable panel. A faint test line should be interpreted according to the manufacturer’s instructions.
• Preliminary Positive / Non-Negative: the control line appears but the applicable test line is absent. This is a preliminary screening result rather than definitive laboratory confirmation.
• Invalid: the required control line does not appear. Do not interpret the affected assay; follow the manufacturer’s procedure for repeating an invalid test.

The pH, SG and creatinine pads use their own reference system and should not be interpreted using the drug-panel C/T line rules.

For additional examples of control lines, faint test lines and invalid results, review our guide on how to read a drug test cup.

Detection Windows, Storage & Limitations

Drug and metabolite detection windows are not fixed values that can be guaranteed for every person or test. Detection can vary according to the target substance, use pattern, metabolism, specimen timing, urine concentration and assay cutoff.

For general educational information, review our urine drug test detection windows guide.

Store and handle this test according to the environmental and temperature requirements listed in the current package insert. Do not use a device after its labeled expiration date or if the sealed packaging has been damaged.

This cup provides preliminary qualitative screening results. It does not report exact drug concentrations, establish exact time of exposure or determine current impairment.

Forensic Use Only

This 13 panel drug test ETG configuration is labeled Forensic Use Only. It should be selected, used and interpreted according to its current product labeling and the requirements of the applicable forensic testing program.

Forensic Use Only status is not interchangeable with CLIA-waived, clinical, OTC or Employment & Insurance status.

For additional information, review our Forensic Use Only product classification and intended-use guidance.

Bulk & Wholesale 13 Panel Drug Test Cups

DrugTestingCup.com offers this 13 panel drug test with fentanyl, EtG and kratom with quantity-based pricing for organizations purchasing forensic screening supplies in volume.

FREE SHIPPING is available on qualifying orders of 100 cups or more, and eligible in-stock orders placed before 3 PM EST can ship the same business day.

Organizations purchasing recurring case quantities, several panel configurations or larger volumes can review our wholesale drug testing supplies options.

Government agencies, probation departments, correctional facilities and authorized contractors requiring procurement support can also review our government drug testing supplier and RFP page.

Frequently Asked Questions

What does this 13 panel drug test ETG screen for?

This configuration includes AMP/1000, BUP/10, BZO/300, COC/300, ETG/300, FEN/20, MDMA/500, MET/1000, MTD/300, OPI/2000, OXY/100, THC/50 and KRA/500 plus pH, specific gravity and creatinine specimen-validity indicators.

Does this 13 panel drug test include fentanyl?

Yes. It includes a dedicated FEN/20 fentanyl screening panel separate from OPI/2000.

Does this test include EtG?

Yes. The configuration contains ETG/300 for preliminary screening of ethyl glucuronide, an alcohol metabolite.

Does this product test for kratom?

Yes. It includes a KRA/500 kratom-related screening panel.

Is KRA/500 the same as a dedicated 7-OH test?

Not necessarily. Buyers specifically requiring 7-hydroxymitragynine screening should verify the target analyte listed in the applicable manufacturer documentation.

What is the opiate cutoff on this product?

This configuration uses an OPI/2000 screening cutoff. Fentanyl, oxycodone, buprenorphine and methadone are represented by separate assays.

What are the three ADLTX indicators?

The cup includes pH, specific gravity and creatinine specimen-validity indicators. They are separate from the 13 drug-screening panels.

Does an unusual ADLTX result prove specimen tampering?

No. An unusual specimen-validity result should be evaluated according to the product instructions and applicable testing procedure and should not automatically be treated as definitive proof of intentional adulteration.

Is this 13 panel drug test CLIA waived?

No. This specific Economy 90 mL configuration is labeled Forensic Use Only.

Can this 13 panel drug test be purchased in bulk?

Yes. Quantity pricing is available, qualifying orders of 100 cups or more receive free shipping, and larger recurring or institutional purchases may qualify for additional wholesale pricing.